SALMOSS Biotech
Chile· Est.
Eco‑friendly bone graft solutions for dental and orthopedic care, leveraging a non‑mammal xenograft platform.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Eco‑friendly bone graft solutions for dental and orthopedic care, leveraging a non‑mammal xenograft platform.
DentalOrthopedics
Technology Platform
A non‑mammal xenograft platform (SALMOSS HAPS) that retains bone mineral and collagen matrix for osteoconduction while employing eco‑friendly manufacturing processes.
Opportunities
Rising demand for sustainable medical materials and potential expansion into broader orthopedic applications.
Risk Factors
Regulatory approval uncertainty for novel xenograft sources and reliance on a single flagship product.
Competitive Landscape
Competes with traditional animal‑derived grafts and synthetic scaffolds; differentiation lies in its eco‑friendly non‑mammal source.